Professional Documents
Culture Documents
Ekstrak Tanaman
Ekstrak Tanaman
19
with Plant Extractives
Objectives
Upon successful completion of this chapter, the student will be able to:
• Differentiate between extracts, fluidextracts, and tinctures on the basis of active drug content.
• Perform calculations related to the concentration and dose of extracted botanicals.
• Perform calculations related to the concentration and dose of botanic dietary supplements.
Currently, the consuming public has renewed interest in the use of botanicals and dietary supple-
ments. These products are widely available to consumers, and a variety of governmental agencies
are trying to ensure their safety by setting appropriate quality standards.1 The United States
Pharmacopeia—National Formulary (USP/NF) includes official monographs, general tests, assays,
and manufacturing practices for a number of botanicals and dietary supplements.2 Included
among the official monographs for botanicals are those for echinacea, feverfew, garlic, ginkgo,
ginseng, goldenseal, hawthorn, Saint John’s wort, saw palmetto, and valerian. Dosage forms may
be prepared from the dried and pulverized plant parts (e.g., leaves) containing the desired
components.
Other pharmaceutical preparations are made by the process of extraction—that is, by remov-
ing desired constituents from plant materials through the use of select solvents. The plant materi-
als (termed crude drugs) include seeds, leaves, bark, or other plant parts that contain known or
suspected active therapeutic ingredients (ATIs) or active ingredients (AIs), including alkaloids,
glycosides, or other pharmacologically active complex organic molecules.
Two major processes are used for the extraction of active constituents from plant materials,
namely maceration and percolation.
The term maceration comes from the Latin macerare, meaning ‘‘to soak.’’ By this process,
comminuted crude drug is placed in a suitable vessel and allowed to soak in a solvent or mixture
of solvents (termed the menstruum) for a sufficient period to soften the botanic material and
effect the extraction of the soluble constituents. The menstruum selected is based on the solubility
characteristics of the desired constituents. Hydroalcoholic mixtures commonly are employed.
The dissolved constituents are separated from the exhausted crude drug (termed the marc) by
straining or filtration.
The term percolation is derived from the Latin per, meaning ‘‘through,’’ and colare, meaning
‘‘to strain.’’ By this process, comminuted crude drug is extracted of its soluble constituents by
the slow passage of a menstruum through a column of the botanic material. The crude drug is
carefully packed in an extraction apparatus (termed a percolator) and allowed to macerate for
a prescribed period of time prior to percolation. Percolators are of various sizes and construction.
Small-glass percolators, cone- or cylindrical-shaped, several inches in diameter, and about 12
319
320 PHARMACEUTICAL CALCULATIONS
inches in height, are available for laboratory use. In contrast, large stainless-steel percolators for
industrial use may be six to eight feet in diameter and 12 to 18 feet in height. An orifice at the
bottom of a percolator permits the convenient removal of the extractive (termed the percolate).
By maceration or percolation, therapeutically active as well as inactive constituents (e.g.,
sugars) that are soluble in the menstruum are extracted. Thus, an extractive is a mixture of plant
constituents.
The primary dosage forms of plant extractives are extracts, fluidextracts, and tinctures. Fre-
quently, however, the active therapeutic ingredient(s) are separated from plant extractives by
physicochemical methods and then chemically identified, purified, and used as single therapeutic
agents in various dosage forms (e.g., tablets, capsules, elixirs, syrups). In some instances, synthetic
replicas of the ATIs, or chemical congeners of them, are prepared and used in pharmaceutical
products rather than the naturally occurring therapeutic agents.
The relative strengths of extracts, fluidextracts, and tinctures are depicted in Figure 19.1, which
shows an example of the quantity of each that may be prepared from a quantity of crude drug.
In terms of equivalency:
1g 1 mL 0.25 g 10 mL
crude drug fluidextract ‘‘400%’’ extract ‘‘potent’’ tincture
100 g
CRUDE
DRUG
OR OR
FIGURE 19.1 Depiction of the relative concentrations of a potent tincture, a fluidextract, and an extract using as
the example a ‘‘10%’’ tincture and a ‘‘400%’’ extract (see text for further explanation).
(c) Since a ‘‘400%’’ extract has four times the AI content as the crude drug, and since the
dose of the crude drug as calculated above is 0.06 g, the dose of the extract would be
1
⁄4 of that dose:
0.06 g 1⁄4 0.015 g or 15 mg, answer.